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Endothelial cells form the internal barrier between circulating blood and the vessel wall. They regulate arterial activity and 
mediate pathological reactions to vascular injuries such as atherosclerosis and balloon angioplasty. The development and dif-
ferentiation of endothelial cells is a complex and coordinated process involving multiple levels of signaling and transcriptional 
and post-transcriptional regulation. Elucidating the mechanism of endothelial differentiation will not only enhance our under-
standing of vascular disease pathogenesis, but also facilitate our ability to produce vessels cells from pluripotent stem cells for 
regeneration purposes. In this review, we discuss the current understanding of how stem cells differentiate into endothelial 
cells at the level of signaling, transcription and microRNA regulation.  
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The vascular system is fundamental for embryonic devel-
opment and adult life because it is essential for the delivery 
of oxygen and nutrients to cells throughout the body. Endo-
thelial cells (ECs) line the internal surface of the entire vas-
cular system and form the barrier between circulating blood 
and the rest of the vessel wall. They serve to prevent 
thrombosis and to regulate arterial activity through synthe-
sis and release of numerous vasoactive molecules. The en-
dothelium is thus considered as a dynamic and heterogene-
ous organ with secretory, metabolic, synthetic and immu-
nological functions [1]. In mammals, two distinct but relat-
ed processes are involved in the establishment of blood 
vessels [2]: First, de novo vasculogenesis generates a primi-
tive network of vasculature through the formation of ECs 
from endothelial precursor cells called angioblasts. Second, 
angiogenesis takes place with vessel expansion and further 
EC sprouting, branching and intussusception. Further spe-
cialization of the endothelial cells into arteries, veins, capil-
laries and lymphatic vessels ensures the proper functioning 
of the vasculature. 
Differentiation of endothelial cells from their precursors 
involves co-operative interaction among many different 
signaling molecules and transcription factors (for reviews, 
see [3,4]). Understanding the molecular mechanism of EC 
differentiation will greatly benefit regenerative methods for 
treating certain vascular diseases, such as atherosclerosis, 
aortic dissections and aneurysms. Various methods have 
been applied to generate endothelial cells from pluripotent 
stem cells, which include embryonic stem cells (ESCs) and 
induced pluripotent stem cells (iPSCs), but often with lim-
ited efficiency. Thus, new techniques and refined protocols 
are needed to produce sufficient numbers of a desired cell 
type for tissue engineering and regenerative medicine. Over 
recent years, there has been great progress in our under-
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standing of how molecules participate in endothelial lineage 
commitment. In this review, we discuss the signaling path-
ways and transcriptional regulation of endothelial differen-
tiation and also the involvement of microRNAs during this 
process. 
1  Signaling pathways involved in the regulation 
of endothelial differentiation 
Establishment of endothelial cells occurs both extraembry-
onically and intraembryonically during mammalian embry-
onic development. In the yolk sac, mesodermal precursors 
of hematopoietic and endothelial lineages differentiate into 
a cluster of cells called blood islands, where cells in the 
inner part of the island give rise to hematopoietic cells and 
cells in the outer part differentiate into endothelial cells [3]. 
The subsequent coalescence of blood islands and the for-
mation of the lumina lead to a primitive vascular plexus. 
Within the embryo, endothelial precursor cells called angi-
oblasts migrate and differentiate to form the primordial aor-
ta. Simultaneous migration of angioblasts from presomitic 
cranial mesoderm forms the endocardial tube in the pericar-
dial area [4].  
Several signaling pathways, including those for hedge-
hog (Hh), vascular endothelial growth factor (VEGF), basic 
fibroblast growth factor (bFGF), bone morphogenetic pro-
tein (BMP), Notch and Wnt, are required for induction of 
endothelial and hematopoietic lineages within the endoderm 
[5]. Although the current model of signaling hierarchy con-
trolling endothelial cell development is largely derived from 
studies of mouse, endothelial differentiation in different 
mammalian species seems to adopt a similar signaling pro-
gram [6,7]. 
1.1  Hedgehog signaling  
Signaling by the Hedgehog family of secreted proteins plays 
a key role in embryonic patterning and morphogenesis [8] 
and is essential for vertebrate blood vessel formation [9]. 
The Hedgehog family consists of three members: sonic 
hedgehog (SHH), Indian hedgehog (IHH) and desert 
hedgehog (DHH). IHH, a primitive endoderm-secreted pro-
tein, is sufficient to induce formation of endothelial and 
hematopoietic cells in the mouse embryo with the endoderm 
removed [10]. SHH, a more widely expressed protein dur-
ing embryogenesis and which shares a redundant role with 
IHH [11], was also shown to be both necessary and suffi-
cient for endothelial tube formation from angioblasts in 
avian embryos [12]. Zebrafish embryos mutant in the SHH 
pathway display a defect in vascularization and a loss of 
arterial differentiation, and overexpression of SHH leads to 
the formation of lumenized ectopic vessels [13]. Embryoid 
bodies formed from mouse embryonic stem cells deficient 
in either Ihh or a receptor component of the Hh pathway, 
Smoothened (Smo), are unable to form blood islands and 
express no endothelial cell markers [14]. However, Ihh 
embryo yolk sacs can form blood vessels, although the ves-
sels are fewer in number and are smaller [14], indicating 
that Hh signaling may play an inductive role in directing 
mesoderm differentiation but not a direct role in endothelial 
cell differentiation. 
1.2  Bone morphogenetic protein signaling  
Bone morphogenetic proteins function downstream of 
Hedgehog signaling [6,7] and are also critical for regulating 
embryonic vascular development. First identified in extracts 
from bone matrix and with a role of promoting bone for-
mation, BMPs are now known as essential regulators of the 
development of nearly all vertebrate organs systems, in-
cluding the embryonic vasculature. Bmp4 knockout mice 
are embryonic lethal due to failed generation of mesoderm 
[15]. Embryos deficient for downstream BMP signaling 
molecule Smad5 lack organized yolk sac vasculature [16]. 
BMP4 initiates efficient induction of mesoderm in human 
embryonic stem cells [17,18] and can promote formation of 
Flk-1+Scl+ hematopoietic and endothelial progenitors [19], 
CD34+ progenitors [20], CD34+CD31+ vascular progenitors 
[21], CD144+KDR+ endothelial progenitors [22] and hemo-
genic endothelium from murine ESCs [23].  
The VEGF receptor, Flk-1, is now recognized as a target 
of BMP signaling. BMP4, via SMAD1/5 signaling, induces 
differentiation of ESCs into Flk-1+ cells in serum-free con-
ditions [19]. Recent studies have identified several tran-
scription factors that mediate BMP4-induced EC differenti-
ation. CXXC5, a nuclear transcription factor containing a 
CXXC-type zinc-finger domain, is induced during endothe-
lial differentiation from mouse ESCs and mediates tran-
scriptional activation of Flk-1 via BMP4-Smad signaling 
[24]. Cxxc5 morpholino-injected zebrafish display defects 
in caudal vein plexus formation, and Cxxc5 mice with 
subcutaneously injected matrigel plugs show suppressed 
BMP4-induced angiogenesis, suggesting that Cxxc5 is re-
quired for vessel formation. ER71/ETV2, a member of the 
ETS (E26 transformation-specific or E-twenty-six) tran-
scription factor family, promotes BMP4-mediated Flk-1+ 
cell development and overexpression can rescue the for-
mation of Flk-1+ mesoderm blocked by BMP [25]. Another 
study showed that Gata2, one of the blast colony-forming 
cell (BL-CFC)-enriched transcripts, was a direct target of 
BMP4 and was able to promote generation of Flk-1+ meso-
derm and Flk-1+Scl+ hemangioblasts [26]. 
1.3  WNT signaling 
The WNT family of proteins are secreted glycoproteins that 
control fundamental aspects of development, including em-
bryonic patterning, cell fate specification, survival, and 
overall organogenesis [27]. There are three main WNT sig-
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naling pathways: the canonical WNT/β-catenin pathway, 
the WNT/Ca2+ pathway, and the planar cell polarity (PCP) 
pathway. Canonical WNT signaling is the most extensively 
studied and plays a critical role in vascular development. 
Deletion of β-catenin in developing endothelial cells leads 
to embryonic death and loss of EC integrity [28]. The ca-
nonical WNT pathway is required for primitive streak for-
mation [29,30] and initial formation of mesoderm from the 
pluripotent epiblast or mouse ESCs. Further differentiation 
of ESCs into hematoendothelial cells still requires canonical 
WNT signaling [31]. Inhibition of WNT leads to decreased 
generation of Flk-1+ cells [32], whereas activation of the 
WNT signal is able to expand Flk-1+ vascular progenitor 
populations [33]. A definite role of WNT signaling in di-
recting differentiation of embryonic stem cells into the en-
dothelial lineage has been identified with Wnt5a deficient 
murine ESCs [34]. Wnt5a mouse ESCs exhibited a defect 
in endothelial differentiation, which could be rescued by 
adding recombinant WNT5a protein. In addition, both the 
canonical β-catenin and the PKCα-mediated non-canonical 
signaling pathways are required for the differentiation of 
mESCs to ECs induced by Wnt5a [34].    
1.4  VEGF signaling 
VEGF signaling is the key regulatory pathway controlling 
vascular development and diverse endothelial cell functions, 
including cell survival, proliferation, migration and vascular 
permeability [35]. Among the five members of the VEGF 
family, which includes VEGFA, VEGFB, VEGFC, VEGFD 
and VEGFE, VEGFA is the most functionally significant 
and best characterized. VEGFA signals via its main recep-
tors, VEGFR1 (fms-related tyrosine kinase-1, Flt-1) and 
VEGFR2 (fetal liver kinase-1, Flk-1), and can also bind to 
semaphorin receptors, neuropilin (NRP)1 and NRP2. The 
impact of VEGFA on endothelial cell development and 
function is mainly achieved through binding to its tyrosine 
kinase receptor VEGFR2 with activation of downstream 
effectors, including PKC, PLCγ, MAPK and the PI3K/Akt/ 
PKB cascade [36]. In contrast to VEGFR2, VEGFR1 func-
tions as a decoy receptor with stronger affinity for VEGFA 
but less tyrosine kinase activity, thus negatively regulating 
VEGF signaling.  
Heterozygous mutants of Vegfa and homozygous mu-
tants of Vegfr2 are embryonic lethal at embryonic day (E) 
1112 and E8.5–9.5, respectively, due to defective 
blood-island formation and impaired vascular development 
[37,38]. However, Flk-1 mouse embryonic stem cells are 
able to differentiate into hematopoietic and endothelial cells, 
although their subsequent migration and expansion requires 
a Flk-1-mediated signal, suggesting that VEGF signaling is 
dispensable for endothelial cell differentiation but may in-
stead regulate EC survival [39,40]. Similarly, VEGF does 
not promote endothelial cell differentiation from human 
embryonic stem cells [7]. For VEGFR2+ mesodermal vas-
cular progenitor cells, phosphorylation of VEGFR2 Y1175 
and subsequent activation of the VEGFR2-PLCγ1 axis and 
downstream Ras signaling is vital for endothelial lineage 
specification [41,42].   
1.5  Notch signaling 
Notch signaling is of vital importance in vascular develop-
ment, and participates in processes such as vascular smooth 
muscle cell differentiation, arterial-venous cell fate specifi-
cation, EC proliferation and angiogenic sprouting [43]. 
However, the role of Notch signaling in endothelial differ-
entiation has not been defined. In growing vascular sprouts, 
VEGF induced the activation of Delta-like/Notch signaling, 
which suppresses tip cell fate in neighboring cells. One re-
cent study expanded the prevailing model, showing that in 
endothelial progenitors (EPs), activation of the Notch path-
way via VEGF-VEGFR2 signaling feeds back to inhibit 
Vegfr2 transcription and thereby limits EP maintenance and 
amplification [44]. Thus, VEGFA stimulation with Notch 
inhibition enhances EP formation and amplification,    
and blocks conversion of EPs to mature ECs. Moreover, 
Notch signaling regulates further EC specification by main-
taining an arterial fate and inhibiting venous or lymphatic 
lineages [45].   
2  Transcriptional and epigenetic regulation of 
endothelial differentiation 
The specification of endothelial lineages requires a coordi-
nated regulation of signaling molecules and transcriptional 
factors as well as epigenetic modifiers to direct endotheli-
al-specific gene expression. The past decade has witnessed 
tremendous progress in dissecting the function of these 
transcription factors; however, the transcriptional regulatory 
network governing endothelial differentiation remains in-
completely understood. Here we summarize several of the 
transcription factors and epigenetic mechanisms that are 
involved. 
2.1  ETS transcription factors 
E-twenty six (ETS) proteins are a group of DNA-binding 
transcription factors that are critical for endothelial devel-
opment. ETS family members share a highly conserved 
ETS domain that binds to a core 5′-GGA(A/T)-3′ sequence 
in target genes. To date, 26 mouse and 27 human ETS pro-
teins have been identified [46], and 19 of them are ex-
pressed in human endothelial cells. All identified endotheli-
al enhancers and promoters contain multiple ETS binding 
motifs [3], indicating that ETS factors may control most 
endothelial-related genes. Among the ETS factors regulat-
ing endothelial development, such as Ets-1, Erg, Fli-1, and 
Etv2, Etv2 (also known as Er71, ETS-related 71) is by far 
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the best characterized.  
During embryogenesis, Etv2 expression is initially wide-
ly spread within the primitive streak mesoderm, and then 
becomes more limited to major vessels at E8.59.5, and 
finally disappears beyond E10.511.5 [25,47]. This dynam-
ic change of Etv2 expression reflects its role in early vascu-
lar development. In fact, Etv2 is a potent activator of several 
early endothelial genes, such as Flk1, Tal1, Mef2c, Pecam 
and Tie2 [3]. Etv2 knockout mice are embryonic lethal due 
to a complete lack of blood vessels and hematopoietic cells 
[25,48], and morpholino knockdown or mutation of etsrp, 
the Etv2 ortholog in zebrafish, results in complete deficien-
cy in endothelial development [49,50]. Etv2 activation is 
critical for driving Flk-1+ mesoderm differentiation and 
specifying Flk-1+ PDGFRα- hematopoietic and endothelial 
cell lineages, while suppressing the Flk-1+ PDGFRα+ cardi-
ac lineage [47,51,52], partly through inhibiting the WNT 
signaling pathway [53]. On the other hand, ensuring a 
tightly controlled Etv2 function is critical for proper devel-
opment of the vascular system. Transgenic mice with con-
stitutive Etv2 expression induced by Tie2-Cre display di-
lated yolk sac vessels accompanied with hemorrhaging and 
are eventually embryonic lethal [54]. In a recent study, tran-
sient Etv2 expression with constitutive Erg1 and Fli1 
co-expression could reprogram amniotic cells into durable 
endothelial cells [55]. In summary, Etv2 plays a central 
early role in endothelial specification and acts near the top 
of the transcriptional network governing endothelial cell 
development. 
ETS factor Fli also acts at the top of the transcriptional 
network governing hematopoietic and endothelial develop-
ment. Knockdown of Fli in Xenopus substantially inhibits 
hematopoietic and endothelial differentiation, and activation 
of Fli transactivates early hemangioblast genes through Scl, 
Etsrp and Cloche [56]. However, disruption of Fli in 
zebrafish fails to recapitulate the defects in Xenopus, and 
Fli1−/− mouse embryos do not display severe vascular de-
fects but die of hemorrhage with loss of vascular integrity 
[57,58], indicating that Fli is dispensable for EC develop-
ment in zebrafish and mouse, but is required for vasculature 
formation after endothelial establishment. As a matter of 
fact, Fli acts downstream of Etv2 via a positive feed-   
forward regulatory loop during vasculogenesis [59]. 
Redundancy between different ETS factors may explain 
the absence of vascular defects in knockout mouse studies. 
Mice with nonfunctional Erg, an ETS factor highly homol-
ogous to Fli, displayed no overt vascular phenotype with 
only dilated vessels in the brain [60]. Subsequent studies 
showed Erg regulated angiogenesis and endothelial survival 
by inducing adhesion molecule VE-cadherin and modulat-
ing HDAC6 function [61,62]. 
2.2  Forkhead transcription factors 
The Forkhead (Fox) transcription factors play essential roles 
in vascular biology and endothelial function, and members 
that are of major importance in endothelial development 
include the FoxC, FoxF, FoxH and FoxO families [63]. 
Foxo1-deficient mice are embryonic lethal due to deregu-
lated vascular development, including malformation of the 
aorta and internal carotid artery branches [64,65]. While 
mice deficient in Foxo3 did not show vascular defects, 
overexpression of Foxo1 and Foxo3 inhibited endothelial 
migration and tube formation, indicating a suppressive role 
of FOXO transcription factors in the regulation of vessel 
formation [66]. Foxf knockout mice showed defective mes-
odermal differentiation and disordered vascular patterning 
in the yolk sac [67]. Foxc1 and Foxc2 knockout mice 
are lethal by E9.5 with defective vascular remodeling and 
arteriovenous malformations [68].  
FoxC proteins are important cofactors for ETS transcrip-
tion factors, which together regulate endothelial gene ex-
pression [69]. Forkhead and ETS transcription factors can 
synergistically activate a composite cis-acting element 
called the FOX:ETS motif present in enhancers or promot-
ers of a variety of endothelial genes such as VE-cadherin, 
Pecam1, Tie2, and Scl [69]. Coexpression of foxC2 and etv2 
induces ectopic expression of vascular genes in Xenopus 
embryos, and simultaneous knockdown of the orthologous 
genes disrupts vascular development in zebrafish embryos 
[69]. In a recent study, foxc1a/b was found to be a direct 
upstream regulator of etsrp in zebrafish [70]. Combined 
knockdown of foxc1a/b led to a significant decrease in etsrp 
expression at early developmental stages, indicating that 
coordination of FoxC with ER71 is critical in mediating EC 
development [70].   
2.3  GATA transcription factors 
GATA transcription factors were initially thought to be re-
quired for hematopoietic development, because some early 
studies showed Gata1 and Gata2 mice to be defective 
in erythropoiesis and to display anemia [71,72]. Subsequent 
studies found GATA also played an important role in he-
mangioblast formation and endothelial development [26]. 
GATA2 can induce the generation of Flk-1+ mesoderm, the 
Flk-1+ Scl+ hemangioblasts and endothelial cells [26]. In 
fact, GATA binding sites are present in several endothelial 
genes, such as Flk1 and VE-cadherin [73,74], and GATA 
regulates the endothelial gene, Endomucin, through epige-
netic modulation [75].     
2.4  Epigenetic modifications  
Epigenetic control of EC differentiation involves DNA 
methylation of endothelial lineage promoters and post- 
translational modification of histones. During differentiation, 
promoter regions of the genes involved in endothelial fate 
determination and homeostasis undergo intensive hypo-
methylation, allowing more efficient transcription [7678]. 
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Early studies showed inhibition of histone deacetylases 
(HDACs), enzymes that remove acetyl groups from lysine 
residues of histone proteins, blocked the endothelial differ-
entiation of adult progenitor cells [79]. In contrast, laminar 
flow-induced activation of HDAC3 can promote EC differ-
entiation [80]. Histone methylation with H3K27me marks 
an epigenetically silenced state, while H3K4me permits 
gene activation. By pharmacologically inhibiting histone 
methyltransferase to reduce repressive H3K27me, endothe-
lial progenitor cells (EPCs) increased expression of endo-
thelial nitric oxide synthase (eNOS), and the reduction of 
H3K27me was associated with an increase in the expression 
of the histone demethylase, Jmjd3 [81]. Ablation of Jmjd3 
expectedly compromised mesoderm and subsequent endo-
thelial differentiation, partly by silencing the mesodermal 
regulator Brachyury and reducing β-catenin recruitment 
[82]. On a practical level, targeting epigenetic repressive 
marks would yield more ECs differentiated from stem cells 
so as to enhance their function for bioengineering applica-
tions [83].   
3  microRNAs and EC differentiation 
microRNAs (miRNAs) are small, non-coding RNAs that 
play important regulatory roles in various aspects of devel-
opment, homeostasis and disease by pairing to the mRNAs 
of protein-coding genes as negative and positive post-  
transcriptional regulators [8486]. miRNAs are known to 
control the self-renewal and differentiation program of ES 
cells [87,88]. Numerous miRNAs have been shown to pro-
mote the differentiation of ESCs into various cell lineages, 
including cardiomyocytes [89], endothelial cells [90], 
smooth muscle cells [91] and skeletal muscle cells [92]. The 
switch from pluripotent to lineage-specific state by miRNAs 
involves repressing the self-renewal program by inhibiting 
core pluripotent factors and inducing the expression of lin-
eage-specific gene products.  
Global expression of miRNAs is essential for vascular 
development. Deletion of dicer in mouse led to embryonic 
death, due to defective blood vessel formation and mainte-
nance [93,94]. In line with this observation, a mouse mutant 
with a hypomorphic dicer1 resulted in female infertility 
caused by impaired growth of new capillary vessels in the 
corpus luteum [95]. Endothelial-selective ablation of dicer 
in mouse led to significant defects in postnatal angiogenesis 
in response to a variety of stimuli such as exogenous VEGF, 
ischemia, and wound healing [96]. Consistent with these 
observations, in vitro studies showed that knockdown of 
Dicer in human endothelial cells reduced capillary sprouting 
and tube formation by silencing several critical target 
miRNAs, such as lef-7f and mir-27b [97,98].  
Roles of several miRNAs, including miR-126 [99,100], 
miR-221 [101], miR-132 [102], miR-218 [103,104], 
miR-23~27~24 clusters [105], miR-27a/b [106] and miR-92 
[107], have been carefully examined in the regulation of 
vascular development, angiogenesis and endothelial func-
tions through the fine-tuning of VEGF, Notch and Slit/Robo 
signaling pathways. Though many of the aforementioned 
miRNAs have been shown to regulate proper EC function, 
little is known about their role in EC differentiation. Some 
recent studies have identified several sets of miRNA that 
may participate during this process [90,108,109], although 
many of them have not been directly tested with respect to 
being able to direct EC differentiation. Here, we summarize 
only those miRNAs with a definite role in promoting EC 
differentiation [110] (Figure 1). 
3.1  miR-21 
As one of the first mammalian miRNAs to be identified, 
miR-21 has been extensively studied and was found to be 
deregulated in many pathological conditions, including 
cancer and organ fibrosis [111]. Apart from its classic role 
as a tumor suppressor, recent studies have highlighted 
miR-21 as an important mediator during pathogenesis of 
cardiovascular disease, including angiogenesis [112], myo-
cardial infarction [113,114] and ischemia/reperfusion [115], 
and in advanced peripheral arterial disease [116]. A recent 
genetic study on deletion of the neuronal repressor REST 
(RE1-silencing transcription factor) in embryonic stem cells 
also indicated a role of miR-21 in regulating stem cell 
self-renewal and differentiation [117]. REST is expressed at 
high levels in mouse embryonic stem cells, and is able to 
suppress a set of miRNAs that suppress stem cell self-  
renewal and promote differentiation. Among them, miR-21 
reduces the expression of pluripotent factors Oct4, Nanog, 
Sox2 and c-Myc and specifically inhibits the self-renewal of  
 
 
Figure 1  Roles of miRNAs in endothelial differentiation. miR-21 pro-
motes endothelial differentiation through inhibition of the PTEN/Akt 
pathway. MiR-21 also increased TGF-β2 production and subsequent EC 
gene activation in a SMAD3-dependent manner. MiR200c and miR-150 
induce endothelial differentiation by transcriptionally de-repressing ZEB1 
expression. miR-181a/b and miR-99b mediate EC lineage specification 
through as yet unknown mechanisms.  
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mouse ES cells. Later studies showed that miR-21 is able to 
regulate differentiation of other cell lineages including 
monocyte-derived dendritic cells (MDDCs) [118], granulo-
cytic cells [119] and adipogenic cells [120].    
Our recent study on endothelial differentiation from in-
duced pluripotent stem cells also indicated a role of miR-21 
in regulating the TGF-β signaling pathway [121]. Overex-
pression of miR-21 in pre-differentiated iPSCs induced ca-
pillary formation in vitro and in vivo, and increased levels 
of TGF-β2 mRNA and secreted protein. TGF-β2, in turn, 
promotes iPSCs differentiation towards the endothelial lin-
eage through a SMAD3-dependent pathway. During endo-
thelial cell differentiation, miR-21 targets the PTEN/Akt 
pathway and PTEN knockdown is required for miR-21 me-
diated upregulation of EC markers in differentiated iPSCs.  
3.2  miRNA-200 family 
The miR-200 family consists of five members: miR-200a, 
miR-200b, miR-200c, miR-141 and miR-429. These five 
miRNAs are located in two separate chromosomal clusters 
with the miR-200b-200a-429 cluster at chromosomal loca-
tion 1p36 and miR-200c-141 cluster at 12p13. By targeting 
E-box-binding homeobox (ZEB) transcription factors,   
the miR-200 family negatively regulate epithelial-to-     
mesenchymal transition (EMT) [122], which is crucial for 
embryogenesis and certain pathophysiological conditions, 
such as wound healing and carcinoma progression [123]. 
Expression of miR-200 is reduced in normal mammary stem 
cells, breast cancer stem cells (CSC) and embryonic carci-
noma cell lines [124] and is up-regulated during ESC dif-
ferentiation [125,126]. Overexpression of miR-200 sup-
presses expression of stem cell factors Bmi1 and Sox2 in 
CSCs and mouse ESCs, and induces differentiation 
[124,126].  
The ZEB-miR-200 interplay is also involved in endothe-
lial differentiation of human ESCs [90]. ZEB1 transcrip-
tionally repress EC-specific gene expression during EC dif-
ferentiation. miR-200c de-represses this effect by inhibiting 
ZEB1 transcription, and thus promotes endothelial lineage 
differentiation. In a Matrigel-CD146+ EC-committing cell 
mixture implanted in mice, blocking ZEB1 signaling can 
rescue the inhibitory effect of miR-200c inhibition on in 
vivo vasculogenesis [90]. Interestingly, miR-200c promotes 
mesoderm specification while repressing neuroectodermal 
differentiation from ESCs [127], suggesting that miR-200c 
may play a cell-autonomous role in mediating EC differen-
tiation from stem cells.  
3.3  miRNA-150  
miR-150 is classically involved in hematopoiesis and regu-
lates cell differentiation in both lymphoid and myeloid lin-
eages [128]. miR-150 is considered to be a tumor suppres-
sive gatekeeper in leukemogenesis [129], and its aberrant 
expression is critical for pathogenesis in a variety of hema-
topoietic malignancies. The impact of miR-150 on endothe-
lial cell differentiation seems similar to that of miR-200c, in 
that miR-150 also promotes endothelial lineage specifica-
tion by transcriptionally repressing ZEB1 expression [90]. 
However, mice deficient in miR-150 are viable, fertile, and 
morphologically normal [130], indicating that the signaling 
networks in which miR-150 functions may not be essential 
for embryonic vasculogenesis, although such discrepancies 
could be attributed to the compensatory effects of other 
molecules in the knockout mice.   
3.4  miRNA-181 
The miR-181 family is composed of six members: miR- 
181a1/2, miR-181b1/2, miR-181c, and miR-181d. They are 
expressed in a number of tissues, including muscle, eye, 
brain, lung and the hematopoietic compartment [131]. 
miR-181 family members play critical roles in controlling 
cardiovascular inflammation by regulating critical signaling 
pathways, such as the NF-B pathway and molecules rele-
vant to endothelial cell activation [132] and immune cell 
homoeostasis [133].  
In a recent study employing miRNA microarray analysis 
during defined stages of EC differentiation from human 
ESCs, miR-181a and -181b were identified as increasing in 
a time-dependent manner to peak in mature hESC-ECs 
[109]. Overexpression of miR-181a and -181b enhanced 
levels of EC-specific genes, increased nitric oxide produc-
tion, and improved hES-EC-induced therapeutic neovascu-
larization in an in vivo model of peripheral ischemia. 
Knockdown of miR-181a and -181b significantly reduced 
vascular endothelial markers and nitric oxide production but 
had no effect on the cell population expressing endothelial 
marker proteins [109], suggesting that miR-181a and -181b 
may not be essential for EC lineage specification. This was 
confirmed in another knockout study of mice deficient in 
miR-181 that showed no obvious gross phenotypic abnor-
malities in terms of growth, development, or survival [134].  
3.5  miR-99 family  
The miRNA-99 family consists of miR-99a, -99b, and -100. 
They predominantly act as tumor suppressors by inducing 
cell cycle arrest [135] and inhibiting cell proliferation [136]. 
The miR-99 family also modulates injury responses, such as 
post-radiation DNA damage [137] and dermal wound heal-
ing [138]. miR-99b was co-identified with miR-181 in the 
study mentioned above as promoting EC differentiation 
from ESCs [109]. Like miR-181, augmentation of miR-99b 
induced EC-specific marker expression and nitric oxide 
generation, but its knockdown did not impact endothelial 
differentiation. This indicates that although capable of pro-
moting EC differentiation from pluripotent ESCs, miR-99 is 
dispensable for EC differentiation. 
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3.6  Other miRNAs  
A series of new miRNAs regulating endothelial differentia-
tion have been identified by Yoo et al. [139141], but none 
of them have been functionally characterized. Among them, 
miR-5739 and miR-6087 modulate the expression of en-
doglin [139,140], miR-6078 targets the E-cadherin (Cdh) 
gene [140], while miR-7641 suppresses expression of 
CXCL1 [141].   
4  Conclusion 
Recent years have witnessed progress in deciphering the 
molecular mechanism of endothelial differentiation; how-
ever, a comprehensive understanding of the exact differen-
tiation program is still far from complete. Tissue engineer-
ing and stem cell therapy has important clinical implications 
for treating vascular diseases such as atherosclerosis and 
artery dissections; therefore, a better understanding of the 
EC differentiation program will greatly facilitate our ability 
to generate vessel cells from pluripotent stem cells. With the 
invention and maturation of iPS techniques, more specifi-
cally tailored cells that can be injected intravascularly will 
be made for producing bio-compatible vessels. As more 
details emerge of how endothelial cells are differentiated 
from stem cells, harnessing these differentiation mecha-
nisms to enable the generation of endothelial cells from 
pluripotent stem cells will undoubtedly have future thera-
peutic implications of clinical value. 
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